Innoviva, Inc. (INVA)

1d ago, source: Yahoo Finance

The gross proceeds to be received by the C BURLINGAME, Calif., February 29, 2024--Innoviva, Inc. (NASDAQ: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties ...

Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress

1mon ago, source: Stockhouse

positive topline Phase 3 data for oral drug zoliflodacin for treatment of uncomplicated gonorrhea Repurchased 1.1 million our common stock for $15.4 million in the fourth quarter of 2023 Innoviva, Inc ...

Innoviva (NASDAQ: INVA)

1mon ago, source: The Motley Fool

Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination ...

Innoviva: Q4 Earnings Snapshot

1mon ago, source: SFGate

BURLINGAME, Calif. (AP) — BURLINGAME, Calif. (AP) — Innoviva Inc. (INVA) on Thursday reported profit of $61.5 million in its fourth quarter. The Burlingame, California-based company said it ...

Innoviva Inc

16d ago, source: U.S. News & World Report

Is M&A Activity Set to Spike in 2024? Corporate bond demand could lead to a spike in M&A activity this year.

Innoviva Inc.

25d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...